Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B

J Antimicrob Chemother. 2004 Aug;54(2):575-7. doi: 10.1093/jac/dkh337. Epub 2004 Jul 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Caspofungin
  • Drug Therapy, Combination
  • Echinocandins
  • Fatal Outcome
  • Fever / complications
  • Humans
  • Immunocompromised Host
  • Leukemia, Myeloid / complications
  • Leukemia, Myeloid / drug therapy
  • Lipopeptides
  • Liposomes
  • Male
  • Middle Aged
  • Mycoses / drug therapy*
  • Mycoses / microbiology
  • Neutropenia / chemically induced
  • Neutropenia / complications
  • Peptides / therapeutic use*
  • Peptides, Cyclic*
  • Trichosporon*

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Liposomes
  • Peptides
  • Peptides, Cyclic
  • Amphotericin B
  • Caspofungin